Verition Fund Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Sell |
27,664
-20,278
| -42% | -$108K | ﹤0.01% | 2692 |
|
|
2025
Q1 | $425K | Buy |
47,942
+14,949
| +45% | +$133K | ﹤0.01% | 2068 |
|
|
2024
Q4 | $452K | Sell |
32,993
-55,910
| -63% | -$767K | ﹤0.01% | 1942 |
|
|
2024
Q3 | $2.44M | Buy |
88,903
+80,411
| +947% | +$2.2M | 0.01% | 921 |
|
|
2024
Q2 | $208K | Buy |
+8,492
| New | +$208K | ﹤0.01% | 1930 |
|
|
2017
Q2 | – | Sell |
-10,662
| Closed | -$205K | – | 1093 |
|
|
2017
Q1 | $205K | Sell |
10,662
-11,774
| -52% | -$226K | 0.02% | 971 |
|
|
2016
Q4 | $374K | Buy |
+22,436
| New | +$374K | 0.03% | 636 |
|
|
2016
Q3 | – | Sell |
-8,931
| Closed | -$273K | – | 1145 |
|
|
2016
Q2 | $273K | Buy |
+8,931
| New | +$273K | 0.03% | 559 |
|